Your browser doesn't support javascript.
loading
A novel class of fast-acting antimalarial agents: Substituted 15-membered azalides.
Peric, Mihaela; Pesic, Dijana; Alihodzic, Sulejman; Fajdetic, Andrea; Herreros, Esperanza; Gamo, Francisco Javier; Angulo-Barturen, Iñigo; Jiménez-Díaz, María Belén; Ferrer-Bazaga, Santiago; Martínez, María S; Gargallo-Viola, Domingo; Mathis, Amanda; Kessler, Albane; Banjanac, Mihailo; Padovan, Jasna; Bencetic Mihaljevic, Vlatka; Munic Kos, Vesna; Bukvic, Mirjana; Erakovic Haber, Vesna; Spaventi, Radan.
Afiliação
  • Peric M; GlaxoSmithKline Research Centre Zagreb Ltd., Zagreb, Croatia.
  • Pesic D; Center for Translational and Clinical Research, Department for Intercellular Communication, University of Zagreb School of Medicine, Zagreb, Croatia.
  • Alihodzic S; GlaxoSmithKline Research Centre Zagreb Ltd., Zagreb, Croatia.
  • Fajdetic A; Fidelta Ltd., Zagreb, Croatia.
  • Herreros E; GlaxoSmithKline Research Centre Zagreb Ltd., Zagreb, Croatia.
  • Gamo FJ; Fidelta Ltd., Zagreb, Croatia.
  • Angulo-Barturen I; GlaxoSmithKline Research Centre Zagreb Ltd., Zagreb, Croatia.
  • Jiménez-Díaz MB; Fidelta Ltd., Zagreb, Croatia.
  • Ferrer-Bazaga S; GlaxoSmithKline, Tres Cantos Medicines Development Campus, Diseases of the Developing World, Tres Cantos (Madrid), Spain.
  • Martínez MS; Medicines for Malaria Venture, Geneva 15, Switzerland.
  • Gargallo-Viola D; GlaxoSmithKline, Tres Cantos Medicines Development Campus, Diseases of the Developing World, Tres Cantos (Madrid), Spain.
  • Mathis A; GlaxoSmithKline, Tres Cantos Medicines Development Campus, Diseases of the Developing World, Tres Cantos (Madrid), Spain.
  • Kessler A; The Art of Discovery, Bizkaia, Basque Country, Spain.
  • Banjanac M; GlaxoSmithKline, Tres Cantos Medicines Development Campus, Diseases of the Developing World, Tres Cantos (Madrid), Spain.
  • Padovan J; The Art of Discovery, Bizkaia, Basque Country, Spain.
  • Bencetic Mihaljevic V; GlaxoSmithKline, Tres Cantos Medicines Development Campus, Diseases of the Developing World, Tres Cantos (Madrid), Spain.
  • Munic Kos V; GlaxoSmithKline, Tres Cantos Medicines Development Campus, Diseases of the Developing World, Tres Cantos (Madrid), Spain.
  • Bukvic M; GlaxoSmithKline, Tres Cantos Medicines Development Campus, Diseases of the Developing World, Tres Cantos (Madrid), Spain.
  • Erakovic Haber V; ABAC Therapeutics, Barcelona, Spain.
  • Spaventi R; GlaxoSmithKline, Research Triangle Park, North Carolina, USA.
Br J Pharmacol ; 178(2): 363-377, 2021 01.
Article em En | MEDLINE | ID: mdl-33085774
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 / 3_ND / 4_TD Problema de saúde: 2_enfermedades_transmissibles / 3_malaria / 4_malaria Assunto principal: Malária / Antimaláricos Limite: Animals Idioma: En Revista: Br J Pharmacol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Croácia
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 / 3_ND / 4_TD Problema de saúde: 2_enfermedades_transmissibles / 3_malaria / 4_malaria Assunto principal: Malária / Antimaláricos Limite: Animals Idioma: En Revista: Br J Pharmacol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Croácia